NewsUp one level
Results from 2B3-201 Dose-ascending Trial Presented at Joint ACTRIMS/ECTRIMS Meeting
The ETPN continues its collaboration and series of nanomedicine articles with the International Innovation magazine, with an overview of nanomedicine based solutions to improve the diagnostics and therapy of Alzheimer's disease.
The Education in Nano Technologies (EduNano) projects is currently assessing industry employment needs and the needs of academic researchers through a survey with the goal to develop online courses.
SPIE Microtechnologies, the European meeting where the latest technologies and applications in nanotechnology, microtechnology, as well as bioMEMs, and medical microdevices, smart sensors and integrated circuits and systems are presented.
New position published in the Jobs' section: Marie Curie - Post-Doctoral Researcher in Drug Development
Procarta Biosystems Ltd, Norwich, UK, in collaboration with the Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase, Florence, Italy, University of East Anglia, Norwich, UK, and Nanovector, Turin, Italy, are looking to recruit an experienced researcher.
The ETPN released its Newsletter 3/2014, compiling internal news but also nanomedicine news, upcoming events, information on future calls, ...
The Opening Session of the European Summit for Clinical Nanomedicine 2014 is now available on YouTube.
Registration for the IMI 2 Info Day on 30 September in Brussels, Belgium is now open, until 23 September, via the event web page.
Dr Laurent Lévy speaks to Hannah Stanwix, Commissioning Editor. L Lévy is the Co-Founder, CEO, President of the Executive Board and a shareholder of Nanobiotix, a clinical-stage nanomedicine company pioneering NanoXray, a novel approach for the local treatment of cancer. L Lévy is the Vice-Chairman of the European Technology Platform on Nanomedicine (ETPN)
euMatch is the new matchmaking tool supporting partnering and partner search for your efficient participation in EU Horizon 2020 programme
As the SME Instrument is a brand new funding opportunity, it was not known what to expect from the first round of applications. As it is said on many occasions, the Instrument is very selective and only the best of the best can succeed.
Nanomedicine is an emerging space with many companies spending on research to explore this field in greater depth. Nanoparticles, which are of one to 100 nm, because of their characteristic of being very small are perfect for reaching cellular levels. Research in this field can open new avenues of treating diseases which were initially considered untreatable.
The parts of the Work Programmes 2014–2015 that relate to 2015 (topics, dates, budget) have, with these revised versions, been updated.
The ETP Nanomedicine is currently expanding its range of collaborations with non-European countries in order to create new opportunities for its members. Besides USA, first contacts have been established with Argentina.
The Fit4Health project organises a webinar on 9th September focussed on the description and implementation of clinical trials in Horizon 2020 proposals.
DG SANCO launched a Public Consultation on the Determination of Potential Health Effects of Nanomaterials Used in Medical Devices
The European Commission and the Scientific Committee on Emerging Newly Identified Health Risks have launched a public consultation on the Preliminary opinion ‘Guidance on the Determination of Potential Health Effects of Nanomaterials Used in Medical Devices’.
The projects launched in the 1st Joint Translational Call in 2009 for research groups operating in the EuroNanoMed II partner countries have been finished.
The Innovative Medicines Initiative2 launched on open consultation for Idea generation and development of Call topics
The EU-Japan Centre is organizing a nanotech mission to Japan targeting EU Cluster and SMEs operating in that sector.
Nanobiomedicine is an international, peer-reviewed, open access scientific journal with an innovative approach, being open to both the readers and the authors (no fee requested).
Press Release: New European research project aims to tackle antibiotic resistance issue raised by WHO via inhalable nanotherapeutics
A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.
EuroNanomed 2 releases a 7-minute video to promote drug delivery using Nanoparticles
Five Public-private partnerships between the EC and industry have today published their first call for proposals, among them IMI2 and ECSEL
A new Guide on Synergies between European Structural and Investment Funds (ESIF), Horizon 2020 and other innovation and competitiveness related EU programmes is now available.
Road Map updated - Action Plan Against the rising threats from Antimicrobial Resistance